ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save people's lives. With our BsAb platforms ‘Grabody-T,’ ‘Grabody-I’ and ‘Grabody-B,’ we have built a robust pipeline of multiple clinical and pre-c...See more
Headquarter Korea, Republic of |
Year founded 2016 (8 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Manager